Mysoline and Solu-cortef drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mysoline (primidone) and Solu-cortef (hydrocortisone sodium succinate). Common drug interactions include cardiac arrest among females and abscess neck among males.

The phase IV clinical study analyzes what interactions people have when they take Mysoline and Solu-cortef. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Mysoline?

Mysoline has active ingredients of primidone. It is often used in essential tremor. eHealthMe is studying from 2,849 Mysoline users. Check the latest studies of Mysoline.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.



On Jul, 13, 2026

13 people who take Mysoline and Solu-cortef together, and have interactions are studied.

Mysoline and Solu-cortef drug interactions.

What are the common drug interactions of Mysoline and Solu-Cortef, by gender? *:

female:

  1. Cardiac arrest
  2. Cardiac disorder
  3. Cardiac failure congestive
  4. Cardiomegaly (increased size of heart than normal)
  5. Cardiovascular disorder (heart diseases)
  6. Cellulitis (infection under the skin)
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  9. Deafness
  10. Decreased appetite

male:

  1. Abscess neck (neck abscesses)
  2. Addison's disease (addison's disease, a hormonal disorder disease)
  3. Arthralgia (joint pain)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Bone disorder
  7. Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
  8. Breast haematoma (blood-filled swelling in the breast)
  9. Cardiac arrest
  10. Cardiac disorder

What are the common drug interactions of Mysoline and Solu-Cortef, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Rash
  2. Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

  1. Cardiac arrest
  2. Cardiac disorder
  3. Cardiac failure congestive
  4. Cardiomegaly (increased size of heart than normal)
  5. Cardiovascular disorder (heart diseases)
  6. Cellulitis (infection under the skin)
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  9. Deafness
  10. Decreased appetite

60+:

  1. Abscess neck (neck abscesses)
  2. Addison's disease (addison's disease, a hormonal disorder disease)
  3. Arthralgia (joint pain)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Bone disorder
  7. Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
  8. Breast haematoma (blood-filled swelling in the breast)
  9. Cardiac arrest
  10. Cardiac disorder

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 11 people, 84.62%
  2. Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 11 people, 84.62%
  3. Hypercalcaemia (elevated calcium (ca+) level in the blood): 6 people, 46.15%
  4. High Blood Pressure: 1 person, 7.69%
  5. High Blood Cholesterol: 1 person, 7.69%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Mysoline and Solu-cortef?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mysoline and Solu-cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mysoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Solu-cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mysoline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Solu-cortef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on primidone and hydrocortisone sodium succinate (the active ingredients of Mysoline and Solu-cortef, respectively), and Mysoline and Solu-cortef (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: